Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL b Supply Disruption — Lupin Pharmaceuticals Inc. (M
Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL b Supply Disruption — Lupin Pharmaceuticals Inc. (M is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL b; Manufacturer: Lupin
| Drug name | Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL b |
|---|---|
| Manufacturer | Lupin Pharmaceuticals Inc. |
| Recall/Disruption reason | Presence of foreign substance: Product complaint of foreign material in reconstituted bottle. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0496-2024 |
| Initiation date | 20240424 |
| Quantity affected | 17,070 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →